Who Paid My Doc
Richard Pollak
Podiatrist, Foot & Ankle Surgery San Antonio, TX Doctor of Podiatric Medicine
NPI 1912923731 CMS profile 313489
8042 Wurzbach Rd, 450, San Antonio, TX 78229
General payments
$31,973
Research payments
$33,148
Ownership & investment interest
$0
Research they led as principal investigator
$6,066,799
Through program year 2025, Richard Pollak of San Antonio, TX is reported in the CMS Open Payments database as having received $31,973 across 125 general payments and $33,148 in research payments paid to them. Separately, studies naming them as principal investigator received $6,066,799 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 96th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $25 | 1 | |
| 2024 | General | $797 | 3 | |
| 2023 | General | $3,115 | 9 | |
| 2022 | General | $3,660 | 8 | |
| 2021 | General | $13,415 | 31 | |
| 2021 | Research | $4,400 | 1 | |
| 2020 | General | $1,033 | 20 | |
| 2019 | General | $9,927 | 53 | |
| 2019 | Research | $28,748 | 4 |
Beside peers
- Richard Pollak
- Podiatrist, Foot & Ankle Surgery median
- Middle half of Podiatrist, Foot & Ankle Surgery
- National median
In program year 2025, general payments to Richard Pollak were reported at $25. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.
Show as a table
| Year | Richard Pollak | Podiatrist, Foot & Ankle Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $9,927 | $389 | $118–$1,406 | $163 |
| 2020 | $1,033 | $191 | $62–$691 | $114 |
| 2021 | $13,415 | $329 | $104–$1,341 | $132 |
| 2022 | $3,660 | $419 | $125–$1,611 | $149 |
| 2023 | $3,115 | $377 | $128–$1,164 | $160 |
| 2024 | $797 | $394 | $134–$1,168 | $164 |
| 2025 | $25 | $424 | $139–$1,306 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
130 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Podiatrist, Foot & Ankle Surgery in Texas
Graham Hamilton
Podiatrist, Foot & Ankle Surgery · Edinburg, TX
Paul Kim
Podiatrist, Foot & Ankle Surgery · Dallas, TX
Sherman Nagler
Podiatrist, Foot & Ankle Surgery · Houston, TX
Michael Downey
Podiatrist, Foot & Ankle Surgery · Southlake, TX
Abdul Nurudeen
Podiatrist, Foot & Ankle Surgery · Houston, TX
Orlando Rivera
Podiatrist, Foot & Ankle Surgery · Houston, TX
Related records
Podiatrist, Foot & Ankle Surgery in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Podiatrist, Foot & Ankle Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.